Skip to main content
Premium Trial:

Request an Annual Quote

Microsynth to Provide Customers with CLC Bio Informatics Tool

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The Swiss genomics services firm Microsynth will provide its customers with access to CLC Bio's high-throughput sequencing data analysis solution through a new agreement, CLC Bio said today.

Under the agreement, all of Microsynth's customers will receive a license for the CLC Genomics Workbench for use in assembly and downstream sequence analysis tasks.

"Microsynth is a prominent provider of sequencing and related services in Europe and has strong relationships with long-term customers, especially in Austria, Germany, and Switzerland," Michel Seidelin, CLC Bio's director of Europe, Middle East, and Africa sales, said in a statement.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.